Vimarsana
Biggest News Aggregation in the World

Page 9 - Query Get News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Query Get. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Query Get Today - Breaking & Trending Today

FDA approves abbreviated new drug application for oral anxiety treatment - Vimarsana News

FDA approves abbreviated new drug application for oral anxiety treatment

ANI Pharmaceuticals Inc. has received FDA approval of its abbreviated new drug application for clorazepate dipotassium tablets, according to a company press release.ANI stated that this is a generic version of Tranxene (clorazepate dipotassium, Sanofi), which is indicated for managing anxiety disorders, according to the FDA package insert.

Source: healio.com
Review of artemisinin derivatives: An artful approach to malaria treatment - Vimarsana News

Review of artemisinin derivatives: An artful approach to malaria treatment

Infectious Disease News | The mosquito is one of the world’s most impactful forces. The breadth of transmissible diseases caused by a mosquito bite, including malaria, has helped shape human history.Malaria is caused by infection of erythrocytes with protozoan parasites of the genus Plasmodium that are transmitted through the bites of infected female Anopheles mosquitoes. In 2020, there were an estimated 241 million

Source: healio.com
Xcopri provides long-term seizure control in patients with focal epilepsy - Vimarsana News

Xcopri provides long-term seizure control in patients with focal epilepsy

Long-term use of Xcopri was safe and reduced seizures by more than 90% in adults with uncontrolled focal seizures, according to results of an open-label extension study published in Neurology. “The findings show that the notable improvement in seizure control that was seen in patients with uncontrolled focal epilepsy is sustained over long term,” Pavel Klein, MD, lead study author and

Source: healio.com
Xenon-VR introduces wearable ophthalmic diagnostic device - Vimarsana News

Xenon-VR introduces wearable ophthalmic diagnostic device

Xenon-VR is launching a medical grade virtual reality headset, Xenon-1, to improve visual field assessments for optometrists and their patients, according to a press release from the company.

Source: healio.com
Combined dose-reduction strategies may reduce contrast use by 80% - Vimarsana News

Combined dose-reduction strategies may reduce contrast use by 80%

By combining dose-reduction strategies, investigators found IV contrast use for CT scans could be reduced by approximately 80%.“Contrast is essential in any situation where we need to assess the blood vessels — for example, for some trauma patients or those with a suspected acute gastrointestinal bleed — and it is also needed for evaluation of certain cancers, such as in the

Source: healio.com